Cite
Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
MLA
Korpelainen, Sini, et al. “Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.” Disease Markers, Aug. 2017, pp. 1–8. EBSCOhost, https://doi.org/10.1155/2017/9805609.
APA
Korpelainen, S., Intke, C., Hämäläinen, S., Jantunen, E., Juutilainen, A., & Pulkki, K. (2017). Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia. Disease Markers, 1–8. https://doi.org/10.1155/2017/9805609
Chicago
Korpelainen, Sini, Carina Intke, Sari Hämäläinen, Esa Jantunen, Auni Juutilainen, and Kari Pulkki. 2017. “Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.” Disease Markers, August, 1–8. doi:10.1155/2017/9805609.